Dudediligence.

Senti Biosciences Holdings, Inc

SNTINASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$0.00Mar ’25$16,000Mar ’26$17,000Jun ’26
Net income, by quarter
−$28.9MSep ’24−$610,000Dec ’24−$14.1MMar ’25−$14.7MJun ’25−$18.1MSep ’25−$14.5MDec ’25−$4.2MMar ’26−$12.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$2.3M$3.3M$2.0M$0.00$22,000
Operating income−$40.4M−$62.1M−$92.7M−$61.0M−$68.8M
Net income−$55.3M−$58.2M−$71.1M−$52.8M−$61.4M
Operating cash flow−$34.6M−$34.9M−$52.4M−$41.4M−$43.4M
Free cash flow−$40.2M−$76.3M−$64.4M−$41.4M−$43.6M
Cash$56.0M$57.6M$35.9M$48.3M$16.4M
Shares outstanding3.0M44.1M4.6M4.8M30.9M